search for books and compare prices
Alex A. Adjei has written 3 work(s)
Search for other authors with the same name
displaying 1 to 3 | at end
show results in order: alphabetically | oldest to newest | newest to oldest
Cover for 9780896039636 Cover for 9781489938398 Cover for 9780120885619
cover image for 9781489938398
Product Description: We are in an exciting era in the war against cancer, with real prospects for novel anticancer drugs that are cancer cell-specific without the toxicities that have been the hallmark of conventional cytotoxic cancer chemotherapy. Advances in cancer cell biology fueled by the molecular biology revolution have resulted in the uncovering of many novel potential molecular targets for cancer therapy...read more
By Alex A. Adjei (editor)

Hardcover:

9780896039636 | Ill edition (Humana Pr Inc, April 1, 2003), cover price $199.00

Paperback:

9781489938398 | Reprint edition (Humana Pr Inc, August 16, 2013), cover price $169.00 | About this edition: We are in an exciting era in the war against cancer, with real prospects for novel anticancer drugs that are cancer cell-specific without the toxicities that have been the hallmark of conventional cytotoxic cancer chemotherapy.

Product Description: 0000000000000 0000000000 0000000000000
By Alex A. Adjei (editor)

Hardcover:

9781603270106 | Humana Pr Inc, November 1, 2009, cover price $135.00 | About this edition: 0000000000000 0000000000 0000000000000

cover image for 9780120885619
Product Description: This book offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents...read more

Hardcover:

9780120885619 | Academic Pr, December 13, 2005, cover price $210.00 | About this edition: This book offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents.

displaying 1 to 3 | at end